{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:00:25Z","timestamp":1778601625870,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ando.2025.101705","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T23:52:28Z","timestamp":1737417148000},"page":"101705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Natural history of medullary thyroid carcinoma in MEN 2 patients carrying a variant at codon 804 in the RET proto-oncogene: A study by the French Neuroendocrine Tumor Group (GTE)"],"prefix":"10.1016","volume":"86","author":[{"given":"Valentine","family":"Suteau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u00fflis","family":"Lebeault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Schlumberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Zalzali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Lasolle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u00eblle","family":"Le Bras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rard","family":"Chabrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Raingeard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Castinetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Caron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Ghander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Mirebeau-Prunier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Rohmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Rodien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1250-345X","authenticated-orcid":false,"given":"Claire","family":"Briet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2025.101705_bib0270","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3747\/co.26.5539","article-title":"Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines","volume":"26","author":"Thomas","year":"2019","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ando.2025.101705_bib0275","doi-asserted-by":"crossref","first-page":"1412942","DOI":"10.3389\/fendo.2024.1412942","article-title":"Critically evaluated key points on hereditary medullary thyroid carcinoma","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2025.101705_bib0280","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1530\/EC-18-0157","article-title":"Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960\u20132014: a nationwide study","volume":"7","author":"Mathiesen","year":"2018","journal-title":"Endocr Connect"},{"key":"10.1016\/j.ando.2025.101705_bib0285","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/imj.14394","article-title":"Multiple endocrine neoplasia: an update","volume":"49","author":"McDonnell","year":"2019","journal-title":"Intern Med J"},{"key":"10.1016\/j.ando.2025.101705_bib0290","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1002\/bjs.10746","article-title":"Long-term outcome of prophylactic thyroidectomy in children carrying RET germline mutations","volume":"105","author":"Machens","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.ando.2025.101705_bib0295","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2025.101705_bib0300","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/humu.23430","article-title":"Genotype-specific progression of hereditary medullary thyroid cancer","volume":"39","author":"Machens","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ando.2025.101705_bib0305","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mrrev.2012.09.002","article-title":"Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form","volume":"752","author":"Figlioli","year":"2013","journal-title":"Mutat Res"},{"key":"10.1016\/j.ando.2025.101705_bib0310","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1089\/thy.2016.0399","article-title":"Nationwide French Study of RET variants detected from 2003 to 2013 suggests a possible influence of polymorphisms as modifiers","volume":"27","author":"Lebeault","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2025.101705_bib0315","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3325\/cmj.2021.62.110","article-title":"Crude annual incidence rate of medullary thyroid cancer and RET mutation frequency","volume":"62","author":"Milicevic","year":"2021","journal-title":"Croat Med J"},{"key":"10.1016\/j.ando.2025.101705_bib0320","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1210\/jc.2017-02529","article-title":"p.Val804Met, the most frequent pathogenic mutation in RET, confers a very low lifetime risk of medullary thyroid cancer","volume":"103","author":"Loveday","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101705_bib0325","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1530\/EC-18-0506","article-title":"Genotype and phenotype landscape of MEN2 in 554 medullary thyroid cancer patients: the BrasMEN study","volume":"8","author":"Maciel","year":"2019","journal-title":"Endocr Connect"},{"key":"10.1016\/j.ando.2025.101705_bib0330","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101705_bib0335","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0003-4266(05)81748-2","article-title":"[RET mutations and preventive treatment of medullary thyroid cancer]","volume":"66","author":"Niccoli-Sire","year":"2005","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2025.101705_bib0340","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/thy.2008.0403","article-title":"Medullary thyroid cancer: management guidelines of the American Thyroid Association","volume":"19","author":"Kloos","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2025.101705_bib0345","first-page":"2415","article-title":"RET mutations in exons 13 and 14 of FMTC patients","volume":"10","author":"Bolino","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.ando.2025.101705_bib0350","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0022-3476(99)70129-0","article-title":"Familial medullary thyroid carcinoma: presymptomatic diagnosis and management in children","volume":"135","author":"Heptulla","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.ando.2025.101705_bib0355","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1097\/01.mlg.0000233509.83679.ee","article-title":"Late-onset medullary carcinoma of the thyroid: need for genetic testing and prophylactic thyroidectomy in adult family members","volume":"116","author":"Shaha","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ando.2025.101705_bib0360","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1210\/jcem.87.4.8403","article-title":"Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804","volume":"87","author":"Lombardo","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101705_bib0365","doi-asserted-by":"crossref","first-page":"e734","DOI":"10.1210\/clinem\/dgad156","article-title":"The changing face of multiple endocrine neoplasia 2A: from symptom-based to preventative medicine","volume":"108","author":"Machens","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101705_bib0370","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1067\/msy.2000.107103","article-title":"Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG-->ATG) mutation","volume":"128","author":"Feldman","year":"2000","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2025.101705_bib0375","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13044-022-00130-8","article-title":"Sporadic medullary thyroid cancer: a systematic review and meta-analysis of clinico-pathological and mutational characteristics predicting recurrence","volume":"15","author":"Cosway","year":"2022","journal-title":"Thyroid Res"},{"key":"10.1016\/j.ando.2025.101705_bib0380","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1210\/clinem\/dgae279","article-title":"Medullary thyroid cancer: single institute experience over three decades and risk factors for recurrence","volume":"109","author":"Abou Azar","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101705_bib0385","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/thy.2023.0482","article-title":"Tumor grade and molecular characteristics associated with survival in sporadic medullary thyroid carcinoma","volume":"34","author":"Censi","year":"2024","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2025.101705_bib0390","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1067\/msy.2000.11\/6\/111080","article-title":"Update on the MEN 2A c804 RET mutation: is prophylactic thyroidectomy indicated?","volume":"128","author":"Frohnauer","year":"2000","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2025.101705_bib0395","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1365-2265.2005.02394.x","article-title":"Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations","volume":"63","author":"Learoyd","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2025.101705_bib0400","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1210\/clinem\/dgae133","article-title":"Pediatric medullary thyroid carcinoma: clinical presentations and long-term outcomes in 144 patients over six decades","volume":"109","author":"Hensley","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101705_bib0405","first-page":"5793","article-title":"RET polymorphisms might be the risk factors for thyroid cancer","volume":"8","author":"Huang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.ando.2025.101705_bib0410","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1210\/jc.2004-1622","article-title":"Germline homozygous mutations at codon 804 in the RET protooncogene in medullary thyroid carcinoma\/multiple endocrine neoplasia type 2A patients","volume":"90","author":"Lesueur","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101705_bib0415","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/jmedgenet-2016-103833","article-title":"New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutations","volume":"53","author":"Romei","year":"2016","journal-title":"J Med Genet"},{"key":"10.1016\/j.ando.2025.101705_bib0420","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/EJE-10-0333","article-title":"Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes","volume":"163","author":"Romei","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2025.101705_bib0425","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.ando.2025.101705_bib0430","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0003-4266(06)72585-9","article-title":"C-cell hyperplasia","volume":"67","author":"Guyetant","year":"2006","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2025.101705_bib0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2010.01453.x","article-title":"RET codon 804 mutations in multiple endocrine neoplasia 2: genotype-phenotype correlations and implications in clinical management","volume":"79","author":"Mukherjee","year":"2011","journal-title":"Clin Genet"},{"key":"10.1016\/j.ando.2025.101705_bib0475","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.surg.2009.09.021","volume":"146","author":"Shifrin","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2025.101705_bib0440","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1089\/thy.2013.0620","article-title":"Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations","volume":"24","author":"Rich","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2025.101705_bib0445","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1089\/105072501750362709","article-title":"Prognostic factors in well-differentiated follicular-derived carcinoma and medullary thyroid carcinoma","volume":"11","author":"Baloch","year":"2001","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2025.101705_bib0450","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2265.1998.00392.x","article-title":"Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d\u2019\u00e9tude des tumeurs \u00e0 calcitonine","volume":"48","author":"Modigliani","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2025.101705_bib0455","doi-asserted-by":"crossref","first-page":"E509","DOI":"10.1210\/jc.2010-1234","article-title":"Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Fran\u00e7ais d\u2019\u00c9tude des Tumeurs Endocrines","volume":"96","author":"Rohmer","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101705_bib0460","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1210\/jcem.85.2.6556","article-title":"Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d\u2019\u00c9tudes des Tumeurs \u00e0 Calcitonine (GETC)","volume":"85","author":"Cohen","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101705_bib0465","doi-asserted-by":"crossref","first-page":"E286","DOI":"10.1210\/jc.2013-3343","article-title":"Progression of medullary thyroid cancer in RET carriers of ATA class A and C mutations","volume":"99","author":"Machens","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101705_bib0470","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1089\/thy.2009.0144","article-title":"Prophylactic thyroidectomy in RET carriers at risk for hereditary medullary thyroid cancer","volume":"19","author":"Machens","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2025.101705_bib0480","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s12020-023-03459-8","article-title":"Clinical presentation of MEN 2A in index vs. non-index patients","volume":"82","author":"Machens","year":"2023","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2025.101705_bib0485","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1067\/msy.2002.123006","article-title":"V804M RET mutation and familial medullary thyroid carcinoma: report of a large family with expression of the disease only in the homozygous gene carriers","volume":"131","author":"Lecube","year":"2002","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2025.101705_bib0490","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1210\/jc.2018-00906","article-title":"Letter to the Editor: \u201cp.Val804Met, the most frequent pathogenic mutation in RET, confers a very low lifetime risk of medullary thyroid cancer\u201d","volume":"103","author":"Machens","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101705_bib0495","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1","article-title":"A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985\u20131995 [see comments]","volume":"83","author":"Hundahl","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ando.2025.101705_bib0500","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis","volume":"276","author":"Eng","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2025.101705_bib0505","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1530\/EJE-13-0050","article-title":"The clinical spectrum of RET proto-oncogene mutations in codon 790","volume":"169","author":"Bihan","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2025.101705_bib0510","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1210\/jc.2011-2046","article-title":"The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center","volume":"97","author":"Elisei","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101705_bib0515","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1210\/jc.2014-4508","article-title":"Reference range of serum calcitonin in pediatric population","volume":"100","author":"Castagna","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101705_bib0520","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1530\/eje.1.02216","article-title":"Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype","volume":"155","author":"Frank-Raue","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2025.101705_bib0525","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/cen.12001","article-title":"Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test?","volume":"78","author":"Pina","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2025.101705_bib0530","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/bjs.10856","article-title":"Prophylactic thyroidectomy in children with multiple endocrine neoplasia type 2","volume":"105","author":"Prete","year":"2018","journal-title":"Br J Surg"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426625000241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426625000241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T08:37:21Z","timestamp":1743928641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426625000241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0003426625000241"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2025.101705","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural history of medullary thyroid carcinoma in MEN 2 patients carrying a variant at codon 804 in the RET proto-oncogene: A study by the French Neuroendocrine Tumor Group (GTE)","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2025.101705","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101705"}}